Within its last year performance, ATYR rose by 110.90%, with highs and lows ranging from $4.22 to $1.39, whereas the simple moving average jumped by 45.78% in the last 200 days.
On January 06, 2025, Cantor Fitzgerald started tracking Atyr Pharma Inc (NASDAQ: ATYR) recommending Overweight. A report published by Wells Fargo on October 04, 2024, Initiated its previous ‘Overweight’ rating for ATYR. Jefferies also rated ATYR shares as ‘Buy’, setting a target price of $9 on the company’s shares in an initiating report dated September 05, 2024. RBC Capital Mkts initiated its ‘Outperform’ rating for ATYR, as published in its report on October 12, 2021. Piper Sandler’s report from September 21, 2021 suggests a price prediction of $19 for ATYR shares, giving the stock a ‘Overweight’ rating. Laidlaw also rated the stock as ‘Buy’.
Analysis of Atyr Pharma Inc (ATYR)
Further, the quarter-over-quarter decrease in sales is -100.00%, showing a negative trend in the upcoming months.
In order to gain a clear picture of Atyr Pharma Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -77.96% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 5.41, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 1.07M can be a very valuable indicator of volatility for ATYR stock. On a monthly basis, the volatility of the stock is set at 7.18%, whereas on a weekly basis, it is put at 7.22%, with a loss of -17.13% over the past seven days. Furthermore, long-term investors anticipate a median target price of $20.00, showing growth from the present price of $3.29, which can serve as yet another indication of whether ATYR is worth investing in or should be passed over.
How Do You Analyze Atyr Pharma Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 2.36%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 63.01% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ATYR shares are owned by institutional investors to the tune of 63.01% at present.
